MedTrace Logo

Disability of Musculoskeletal Origin in Community-dwelling Elderly

NCT00311103 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2014-09-15

No results posted yet for this study

Summary

Objectives: To assess the efficacy of an intervention program targeted to the elderly with recent-onset disability of musculoskeletal origin (DIMS), and to perform its economic evaluation.

Conditions

  • Musculoskeletal Diseases

Interventions

PROCEDURE

Specific clinical care program

The rheumatologists acted as principal care providers in regular visits, home visits and phone contacts. The visits were structured following specific proceedings for the different diagnoses based on previously demonstrated approaches. Such protocols included education and promotion of independence, pharmacological and no pharmacological treatment, and timing of diagnostic tests in a stepwise manner. The program also incorporated administrative duties such as the prescription of medication for the patients. Patients were seen as often as necessary according to the medical rheumatologist decision (until the episode of disability was medically resolved).

Sponsors & Collaborators

  • Fundacion MAPFRE

    collaborator OTHER

  • Fundación Mutua Madrileña

    collaborator OTHER

  • Instituto de Salud Carlos III

    collaborator OTHER_GOV

  • La Caixa Foundation

    collaborator OTHER

  • Spanish Foundation of Rheumatology

    lead OTHER

Principal Investigators

  • Juan A. Jover, MD, PhD · IMSALUD

  • Loreto Carmona, MD, PhD · Spanish Foundation of Rheumatology

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00311103 on ClinicalTrials.gov